Search results for: Health Data and Statistics
Filter search results
OHE Posters at HTAi: Tokyo 2016
24 May 2016
…facilitate evidence collection that meets the demands of regulators and HTA bodies, and to make the most of health care information and the role it can play in improving patient…
Adult vaccination programmes deliver socio-economic benefits up to 19 times initial investment, according to new report
18 April 2024
…doctor and hospital visits, meaning valuable resources can be allocated elsewhere, and ensuring a healthy and active workforce throughout life can boost economic productivity. The data also demonstrates that adult…
OHE at the PROMs Research Conference 2017
5 June 2017
…of EQ-5D states observed in any given data set – the Health State Density Index and Health State Density Curve, and estimated Power Law functions. This research, funded by the…
Comparing Preference-based Outcome Measures for Overactive Bladder: EQ-5D-5L vs OAB-5D
31 January 2018
…the health states associated with a given health condition before and after treatment are an essential component of such analyses and are often derived using preference-based measures of health such…
Approaches, Challenges and Successful Stories of Multi-indication Pricing in Europe
28 November 2018
…the US, has identified concerns with respect to inadequate data capabilities to monitor the prescription of different indications, legal and regulatory hurdles, and inflexibility of formulary structure to accommodate multi-indications….
Quality of Life and Rare Disease: Lessons from Spinal Muscular Atrophy
2 April 2019
…for improving the quantity and quality of data available to inform decisionmakers in the context of rare diseases: Bespoke data collection which is relevant to health technology assessment decisionmakers; Simple…
Due to the Unprecedented Nature of H.R. 3, the CBO Analysis is Unreliable and Can’t Inform Policymaking
15 September 2021
…extent of the substantial uncertainty surrounding the potential impact of H.R.3 on pharmaceutical innovation and, ultimately, on patient and population health. The CBO Baseline is Wrong: The Pace of Innovation…
Assessment of the Impact of Orphan Medicinal Products on the European Economy and Society
1 November 2010
…the European economy and society. This study collected data on several indicators of activity, completed a confidential survey of companies developing OMP, concluded four case studies and undertook a literature…
NHS Outcomes, Performance and Productivity
3 March 2008
…at a senior and expert level, covering: economics, medicine, epidemiology, management and policy; public and private health care sector viewpoints; and health professional, patient and general public perspectives. To inform…